الفهرس 
EpidemiologyOnly 14 pages are availabe for public view
 |  | from | 166 |  |  |
| | | from | 166 | | |
Abstract
Hepatic encephalopathy(HE)is a neuropsychiatric complication of liver cirrhosis.Hepatic encephalopathy is associated with poor survival and detrimental effects on quality of life (QOL).The drawbacks of the long-term use of rifaximin in HE necessitates searching for alternative therapies. In this context, our study aimed at evaluating the safety and efficacy of nitazoxanide(NTZ)as compared to rifaximin(RFX)in preventing the recurrence of HE and assessing its impact on QOL.